Linus Angenendt

No current affiliations available for this person. The person is no longer active at the university.

Functions and Memberships
since 2015	Castleman Disease Collaborative Network (CDCN)

Publications

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Gromoll, Jörg; Schlatt, Stefan; Exeler, Rita; Bleckmann, Annalen; Lenz, Georg; Wolf, Sebastian; Steffen, Björn; Berdel, Wolfgang Eduard; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus (2024) In: Blood Advances, 8(1), 70-79. doi:10.1182/bloodadvances.2023011076 Research article (journal) \| Peer reviewed \| Published
Cell Selection-based Data Reduction Pipeline for Whole Slide Image Analysis of Acute Myeloid Leukemia Kockwelp, Jacqueline; Thiele, Sebastian; Kockwelp, Pascal; Bartsch, Jannis; Schliemann, Christoph; Angenendt, Linus; Risse, Benjamin (2022) In: IEEE/CVF (eds.), The IEEE / CVF Computer Vision and Pattern Recognition Conference (CVPR). IEEE Xplore. Research article in digital collection (conference) \| Peer reviewed \| Published
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), . (kein Verlag angegeben). doi:10.1016/j.annonc.2020.08.677 Research article in edited proceedings (conference) \| Peer reviewed \| Published
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6). doi:10.3390/cancers12061488 Research article (journal) \| Peer reviewed \| Published
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor Brand C., Schliemann C., Ring J., Kessler T., Bäumer S., Angenendt L., Mantke V., Ross R., Hintelmann H., Spieker T., Wardelmann E., Mesters R., Berdel W., Schwöppe C. (2016) In: Oncotarget, 7(6), 6774-6789. doi:10.18632/oncotarget.6725 Research article (journal) \| Peer reviewed \| Published

Show all publications

Prizes

Paper of the Month 2024
Awarded by: Medizinische Fakultät der Universität Münster
Award given to: Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus
Announced at: 15/03/2024 | Date of awarding: 15/03/2024
Type of distinction: Best publication award

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Kockwelp, Jacqueline; Thiele, Sebastian; Bartsch, Jannis; Haalck, Lars; Gromoll, Jörg; Schlatt, Stefan; Exeler, Rita; Bleckmann, Annalen; Lenz, Georg; Wolf, Sebastian; Steffen, Björn; Berdel, Wolfgang Eduard; Schliemann, Christoph; Risse, Benjamin; Angenendt, Linus (2024) In: Blood Advances, 8(1), 70-79. doi:10.1182/bloodadvances.2023011076 Research article (journal) \| Peer reviewed \| Published
Cell Selection-based Data Reduction Pipeline for Whole Slide Image Analysis of Acute Myeloid Leukemia Kockwelp, Jacqueline; Thiele, Sebastian; Kockwelp, Pascal; Bartsch, Jannis; Schliemann, Christoph; Angenendt, Linus; Risse, Benjamin (2022) In: IEEE/CVF (eds.), The IEEE / CVF Computer Vision and Pattern Recognition Conference (CVPR). IEEE Xplore. Research article in digital collection (conference) \| Peer reviewed \| Published
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), . (kein Verlag angegeben). doi:10.1016/j.annonc.2020.08.677 Research article in edited proceedings (conference) \| Peer reviewed \| Published
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6). doi:10.3390/cancers12061488 Research article (journal) \| Peer reviewed \| Published
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor Brand C., Schliemann C., Ring J., Kessler T., Bäumer S., Angenendt L., Mantke V., Ross R., Hintelmann H., Spieker T., Wardelmann E., Mesters R., Berdel W., Schwöppe C. (2016) In: Oncotarget, 7(6), 6774-6789. doi:10.18632/oncotarget.6725 Research article (journal) \| Peer reviewed \| Published

Linus Angenendt

Functions and Memberships

Publications

Prizes

Contact

Top-Links